Drug intelligence / Profile preview

para-toluenesulfonamide

Development stage
Phase 3
Lead developer
Gongwin Biopharm
Modality
Small Molecules
Administration
Intratumoral, Intrapleural, Intra-arterial
01

Overview

Para-toluenesulfonamide is a small molecule sulfonamide compound with the chemical formula C7H9NO2S. It has been investigated as an antineoplastic agent and exhibits anti-tumor activity in several cancer types, including hepatocellular carcinoma, non-small cell lung cancer, tongue squamous cell carcinoma, and castration-resistant prostate cancer. Its mechanism of action involves inhibition of carbonic anhydrase II and III enzymes as well as induction of lysosomal membrane permeabilization leading to lysosome-mediated cell death. Para-toluenesulfonamide can disrupt cholesterol content in lipid rafts and modulate survival kinase pathways such as Akt/mTOR/p70S6K. It is also used industrially as a plasticizer and pharmaceutical intermediate[1][2][3][4][5][7].

Brand names
Yiganxin
Other names
p-toluenesulfonamide4-methylbenzenesulfonamide4-toluenesulfonamidebenzenesulfonamide, 4-methyl-p-methylbenzenesulfonamidep-toluenesulfonylamidep-tosylamidetolbutamide impurity atoluene-4-sulphonamidetoluene4-sulphonamidetoluene 4-sulphonamidetoluenesulfonamide, p-
02

Targets

CA9 (Carbonic anhydrase IX)CA1 (Carbonic anhydrase 1)CA2 (Carbonic Anhydrase 2)CA12 (Carbonic anhydrase XII)

Beyond the preview

Go deeper on para-toluenesulfonamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on para-toluenesulfonamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call